Quick Links

External

Team led by MNI researcher receive $6.1 million to study MS

A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis.

The International Progressive MS Alliance has awarded three $6.1 million Collaborative Network Award grants for a total investment of $18.4 million toward accelerating the pace of progressive MS research. More than 2.3 million people worldwide live with MS and more than one million of those living with the disease have progressive MS.

Published: 20Sep2016

MARK NICKERSON MEMORIAL LECTURE - Matthias Hentze

3Oct201601:00
to
02:00

McIntyre Medical Building, 3655 promenade Sir William Osler

Room 1345

Matthias W. Hentze, Prof.Dr.med., ML, FAA

Director, European Molecular Biology Laboratory (EMBL)

A Brilliant Night Brain Cancer Fundraiser

19Oct201618:30
to
23:30

The inaugural A Brilliant Night, in 2015 at the Rio Tinto Alcan Planetarium, raised an astounding $690,000 for brain tumour research.

Dr. Guy Rouleau elected to Royal Society of Canada

The Neuro’s director, Dr. Guy Rouleau, has received yet another honour in recognition of his sterling scientific career. The Royal Society of Canada (RSC) announced on Sept. 7 that its members had elected Dr. Rouleau as one of its new Fellows. He joins a currently active membership of more than 2,000 highly distinguished scientists, scholars and artists who nominate and elect up to 75 new members each year.

Published: 8Sep2016

Continuing the fight against brain cancer

Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman

 

With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.

Published: 31Aug2016

Researchers find new role for cannabinoids in vision

Chemicals shown to improve low-light vision of tadpoles by sensitizing retinal cells

A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.

Published: 25Aug2016

Dr. Boris Bernhardt joins the BIC as new Principal Investigator

We are fortunate to welcome Dr. Boris Bernhardt as BIC core Faculty Member as of August 1, 2016. Boris is a new Assistant Professor in the Department of Neurology and Neurosurgery at McGill and a member of the Epilepsy research group at the MNI. He obtained his PhD in Neuroscience at McGill in 2011 and carried out postdoctoral studies at the Max-Planck Institute for Cognitive and Brain Sciences in Leipzig, Germany. Boris heads the newly-founded Multimodal Imaging and Connectome Analysis Lab at the BIC.

Published: 22Aug2016

Pages